Growth Metrics

Palisade Bio (PALI) Cash & Equivalents Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -51.77%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 24.73%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -28.55%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 13.33%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -16.07%
7 Evaxion A 62.56 Bn 62.54 Bn - 21.66%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.88%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 36.53%
10 Palisade Bio 439.25 Mn 309.68 Mn - 113.59%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 113.59%
Dec 31, 2025 120.30%
Sep 30, 2025 -27.97%
Jun 30, 2025 2.84%
Mar 31, 2025 2.86%
Dec 31, 2024 -2.38%
Sep 30, 2024 -17.08%
Jun 30, 2024 -3.55%
Mar 31, 2024 163.69%
Dec 31, 2023 159.31%
Sep 30, 2023 173.19%
Jun 30, 2023 121.03%
Mar 31, 2023 9.85%
Dec 31, 2022 34.28%
Sep 30, 2022 24.20%
Jun 30, 2022 29.72%
Mar 31, 2022 18.38%
Dec 31, 2021 21.95%
Sep 30, 2021 34.96%
Jun 30, 2021 21.28%
Mar 31, 2021 -60.16%
Dec 31, 2020 -52.55%
Sep 30, 2020 -56.40%
Jun 30, 2020 -38.22%
Mar 31, 2020 -4.95%
Dec 31, 2019 -30.44%
Sep 30, 2019 8.75%
Jun 30, 2019 -41.04%
Mar 31, 2019 -19.30%
Dec 31, 2018 7.06%
Sep 30, 2018 -24.12%
Jun 30, 2018 -6.40%
Mar 31, 2018 -10.56%
Dec 31, 2017 -18.91%
Sep 30, 2017 -8.79%
Jun 30, 2017 -24.94%
Mar 31, 2017 -13.97%
Dec 31, 2016 -3.38%
Sep 30, 2016 -29.79%
Jun 30, 2016 -0.11%
Mar 31, 2016 -15.56%
Dec 31, 2015 -14.11%
Sep 30, 2015 9.97%
Jun 30, 2015 50.45%
Mar 31, 2015 38.25%
Dec 31, 2014 74.60%
Sep 30, 2014 41.73%
Jun 30, 2014 35.36%
Mar 31, 2014 28.99%
Dec 31, 2013 22.07%
Sep 30, 2013 12.28%
Jun 30, 2013 -7.32%